Aquestive Therapeutics, Inc.

AQST

$5.35

-0.56%-$0.03

High—

Low—

52W High-29.1%

Rel. vol—

Interval

Range6.5h

Volume—SMA5SMA10

—

AI analysis

Aquestive Therapeutics, Inc. is showing mixed intraday momentum with consolidation near key moving averages and heightened sensitivity to liquidity shifts.

Upside confirmation strengthens on sustained reclaim above short-term trend anchors.
Breakdown risk rises if support fails with accelerating sell volume.
Relative strength versus sector peers remains neutral-to-slightly positive.

Latest indicator snapshot

Live technical and fundamental context, tuned for quick reads.

SMA5

$5.33

5-period simple moving average

SMA10

$5.31

10-period simple moving average

SMA20

$5.30

20-period simple moving average

SMA50

$5.27

50-period simple moving average

EMA5

$5.33

5-period exponential moving average

EMA10

$5.32

10-period exponential moving average

EMA20

$5.30

20-period exponential moving average

DEMA20

$5.32

Double exponential moving average

Fibonacci

Retracement

Retracement levels

VWAP

$5.29

Volume weighted average price

MACD

0.016

Signal 0.012

RSI(14)

75.0

Relative strength oscillator

OBV

-61.90K

On-balance volume

StochRSI

75.0 / 75.0

Fast oscillator pair

BBands Low

$5.26

Lower band

BBands Mid

$5.30

Middle band

BBands High

$5.34

Upper band

Market Cap

671.25M

Company size

P/E Ratio

0.00

Valuation multiple

EV / EBITDA

-1.81

Enterprise value multiple

ROE

0.0%

Return on equity

ROA

-29.2%

Return on assets

Operating Margin

-59.5%

Operating efficiency

Net Margin

-144.6%

Bottom-line profitability

Current Ratio

—

Short-term liquidity

Debt / Equity

—

Balance-sheet leverage

Dividend Yield

0.0%

Income yield

FCF Yield

—

Free cash flow yield

Beta

1.43

Market sensitivity

52W High

$7.55

52-week peak

52W Low

$2.93

52-week trough

Supply Chain of AQST

Upstream / Downstream / Proxies

Upstream

Active Pharmaceutical Ingredient (API) Suppliers — Buprenorphine/Naloxone (for Suboxone)Active Pharmaceutical Ingredient (API) Suppliers — Clobazam (for Sympazan)Active Pharmaceutical Ingredient (API) Suppliers — Diazepam (for Libervant)Active Pharmaceutical Ingredient (API) Suppliers — Epinephrine Prodrug (for Anaphylm)Polymer and Excipient Suppliers (PharmFilm components)Packaging Material Suppliers

Downstream

Indivior PLCNASDAQ:INDVHypera S.A.BOVESPA:HYPE3Haisco Pharmaceutical Group Co., Ltd.SZSE:002737Mitsubishi Tanabe Pharma America (MTPA)TSE:4188Zambon S.p.A.Assertio Holdings, Inc.NASDAQ:ASRTCosette Pharmaceuticals, Inc.Zevra Therapeutics, Inc. (formerly KemPharm)NASDAQ:ZVRACommave Therapeutics SAPharmanovia

Proxies

Indivior PLCNASDAQ:INDV Zevra Therapeutics, Inc.NASDAQ:ZVRA Assertio Holdings, Inc.NASDAQ:ASRTHypera S.A.BOVESPA:HYPE3

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer